Selected research
Industry Research
Promethazine Hydrochloride Injection Industry Research Report 2026
Market perspective
The global Promethazine Hydrochloride Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Promethazine Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Promethazine Hydrochloride Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Promethazine Hydrochloride Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Promethazine Hydrochloride Injection include Southwest Pharmaceutical, Tianjin Jinyao Group, Shanghai Shyndec Pharmaceutical, Shanghai Harvest Pharmaceutical, Sanofi, Jinling Pharmaceutical, Jilin Centennium Hanke Pharmacy, Pfizer and Hunan Hansen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Promethazine Hydrochloride Injection market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Promethazine Hydrochloride Injection Market by Company
Southwest Pharmaceutical
Tianjin Jinyao Group
Shanghai Shyndec Pharmaceutical
Shanghai Harvest Pharmaceutical
Sanofi
Jinling Pharmaceutical
Jilin Centennium Hanke Pharmacy
Pfizer
Hunan Hansen
Guangdong Southland Pharmaceutical
Hikma Pharmaceuticals
Advacare Pharma
Promethazine Hydrochloride Injection Segment by Type
Intravenous Drip
Intramuscular Injection
Promethazine Hydrochloride Injection Segment by Application
Hospital
Clinics
Other
Promethazine Hydrochloride Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Promethazine Hydrochloride Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Promethazine Hydrochloride Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Promethazine Hydrochloride Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Promethazine Hydrochloride Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Promethazine Hydrochloride Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Promethazine Hydrochloride Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Intravenous Drip
- Intramuscular Injection
Applications
- Hospital
- Clinics
- Other
Companies covered
- Southwest Pharmaceutical
- Tianjin Jinyao Group
- Shanghai Shyndec Pharmaceutical
- Shanghai Harvest Pharmaceutical
- Sanofi
- Jinling Pharmaceutical
- Jilin Centennium Hanke Pharmacy
- Pfizer
- Hunan Hansen
- Guangdong Southland Pharmaceutical
- Hikma Pharmaceuticals
- Advacare Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Promethazine Hydrochloride Injection Market Size (2021-2032)
- 2.2.2 Global Promethazine Hydrochloride Injection Sales (2021-2032)
- 2.2.3 Global Promethazine Hydrochloride Injection Market Average Price (2021-2032)
- 2.3 Promethazine Hydrochloride Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Intravenous Drip
- 2.3.3 Intramuscular Injection
- 2.4 Promethazine Hydrochloride Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinics
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Promethazine Hydrochloride Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Promethazine Hydrochloride Injection Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Promethazine Hydrochloride Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Promethazine Hydrochloride Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Promethazine Hydrochloride Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Promethazine Hydrochloride Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Promethazine Hydrochloride Injection, Product Type & Application
- 3.8 Global Manufacturers of Promethazine Hydrochloride Injection, Established Date
- 3.9 Global Promethazine Hydrochloride Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Southwest Pharmaceutical
- 4.1.1 Southwest Pharmaceutical Company Information
- 4.1.2 Southwest Pharmaceutical Business Overview
- 4.1.3 Southwest Pharmaceutical Promethazine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Southwest Pharmaceutical Promethazine Hydrochloride Injection Product Portfolio
- 4.1.5 Southwest Pharmaceutical Recent Developments
- 4.2 Tianjin Jinyao Group
- 4.2.1 Tianjin Jinyao Group Company Information
- 4.2.2 Tianjin Jinyao Group Business Overview
- 4.2.3 Tianjin Jinyao Group Promethazine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Tianjin Jinyao Group Promethazine Hydrochloride Injection Product Portfolio
- 4.2.5 Tianjin Jinyao Group Recent Developments
- 4.3 Shanghai Shyndec Pharmaceutical
- 4.3.1 Shanghai Shyndec Pharmaceutical Company Information
- 4.3.2 Shanghai Shyndec Pharmaceutical Business Overview
- 4.3.3 Shanghai Shyndec Pharmaceutical Promethazine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Shanghai Shyndec Pharmaceutical Promethazine Hydrochloride Injection Product Portfolio
- 4.3.5 Shanghai Shyndec Pharmaceutical Recent Developments
- 4.4 Shanghai Harvest Pharmaceutical
- 4.4.1 Shanghai Harvest Pharmaceutical Company Information
- 4.4.2 Shanghai Harvest Pharmaceutical Business Overview
- 4.4.3 Shanghai Harvest Pharmaceutical Promethazine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Shanghai Harvest Pharmaceutical Promethazine Hydrochloride Injection Product Portfolio
- 4.4.5 Shanghai Harvest Pharmaceutical Recent Developments
- 4.5 Sanofi
- 4.5.1 Sanofi Company Information
- 4.5.2 Sanofi Business Overview
- 4.5.3 Sanofi Promethazine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Sanofi Promethazine Hydrochloride Injection Product Portfolio
- 4.5.5 Sanofi Recent Developments
- 4.6 Jinling Pharmaceutical
- 4.6.1 Jinling Pharmaceutical Company Information
- 4.6.2 Jinling Pharmaceutical Business Overview
- 4.6.3 Jinling Pharmaceutical Promethazine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Jinling Pharmaceutical Promethazine Hydrochloride Injection Product Portfolio
- 4.6.5 Jinling Pharmaceutical Recent Developments
- 4.7 Jilin Centennium Hanke Pharmacy
- 4.7.1 Jilin Centennium Hanke Pharmacy Company Information
- 4.7.2 Jilin Centennium Hanke Pharmacy Business Overview
- 4.7.3 Jilin Centennium Hanke Pharmacy Promethazine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Jilin Centennium Hanke Pharmacy Promethazine Hydrochloride Injection Product Portfolio
- 4.7.5 Jilin Centennium Hanke Pharmacy Recent Developments
- 4.8 Pfizer
- 4.8.1 Pfizer Company Information
- 4.8.2 Pfizer Business Overview
- 4.8.3 Pfizer Promethazine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Pfizer Promethazine Hydrochloride Injection Product Portfolio
- 4.8.5 Pfizer Recent Developments
- 4.9 Hunan Hansen
- 4.9.1 Hunan Hansen Company Information
- 4.9.2 Hunan Hansen Business Overview
- 4.9.3 Hunan Hansen Promethazine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Hunan Hansen Promethazine Hydrochloride Injection Product Portfolio
- 4.9.5 Hunan Hansen Recent Developments
- 4.10 Guangdong Southland Pharmaceutical
- 4.10.1 Guangdong Southland Pharmaceutical Company Information
- 4.10.2 Guangdong Southland Pharmaceutical Business Overview
- 4.10.3 Guangdong Southland Pharmaceutical Promethazine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Guangdong Southland Pharmaceutical Promethazine Hydrochloride Injection Product Portfolio
- 4.10.5 Guangdong Southland Pharmaceutical Recent Developments
- 4.11 Hikma Pharmaceuticals
- 4.11.1 Hikma Pharmaceuticals Company Information
- 4.11.2 Hikma Pharmaceuticals Business Overview
- 4.11.3 Hikma Pharmaceuticals Promethazine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Hikma Pharmaceuticals Promethazine Hydrochloride Injection Product Portfolio
- 4.11.5 Hikma Pharmaceuticals Recent Developments
- 4.12 Advacare Pharma
- 4.12.1 Advacare Pharma Company Information
- 4.12.2 Advacare Pharma Business Overview
- 4.12.3 Advacare Pharma Promethazine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Advacare Pharma Promethazine Hydrochloride Injection Product Portfolio
- 4.12.5 Advacare Pharma Recent Developments
5 Global Promethazine Hydrochloride Injection Market Scenario by Region
- 5.1 Global Promethazine Hydrochloride Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Promethazine Hydrochloride Injection Sales by Region: 2021-2032
- 5.2.1 Global Promethazine Hydrochloride Injection Sales by Region: 2021-2026
- 5.2.2 Global Promethazine Hydrochloride Injection Sales by Region: 2027-2032
- 5.3 Global Promethazine Hydrochloride Injection Revenue by Region: 2021-2032
- 5.3.1 Global Promethazine Hydrochloride Injection Revenue by Region: 2021-2026
- 5.3.2 Global Promethazine Hydrochloride Injection Revenue by Region: 2027-2032
- 5.4 North America Promethazine Hydrochloride Injection Market Facts & Figures by Country
- 5.4.1 North America Promethazine Hydrochloride Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Promethazine Hydrochloride Injection Sales by Country (2021-2032)
- 5.4.3 North America Promethazine Hydrochloride Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Promethazine Hydrochloride Injection Market Facts & Figures by Country
- 5.5.1 Europe Promethazine Hydrochloride Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Promethazine Hydrochloride Injection Sales by Country (2021-2032)
- 5.5.3 Europe Promethazine Hydrochloride Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Promethazine Hydrochloride Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Promethazine Hydrochloride Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Promethazine Hydrochloride Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Promethazine Hydrochloride Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Promethazine Hydrochloride Injection Market Facts & Figures by Country
- 5.7.1 South America Promethazine Hydrochloride Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Promethazine Hydrochloride Injection Sales by Country (2021-2032)
- 5.7.3 South America Promethazine Hydrochloride Injection Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Promethazine Hydrochloride Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Promethazine Hydrochloride Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Promethazine Hydrochloride Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Promethazine Hydrochloride Injection Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Promethazine Hydrochloride Injection Sales by Type (2021-2032)
- 6.1.1 Global Promethazine Hydrochloride Injection Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Promethazine Hydrochloride Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Promethazine Hydrochloride Injection Revenue by Type (2021-2032)
- 6.2.1 Global Promethazine Hydrochloride Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Promethazine Hydrochloride Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Promethazine Hydrochloride Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Promethazine Hydrochloride Injection Sales by Application (2021-2032)
- 7.1.1 Global Promethazine Hydrochloride Injection Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Promethazine Hydrochloride Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Promethazine Hydrochloride Injection Revenue by Application (2021-2032)
- 7.2.1 Global Promethazine Hydrochloride Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Promethazine Hydrochloride Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Promethazine Hydrochloride Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Promethazine Hydrochloride Injection Value Chain Analysis
- 8.1.1 Promethazine Hydrochloride Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Promethazine Hydrochloride Injection Production Mode & Process
- 8.2 Promethazine Hydrochloride Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Promethazine Hydrochloride Injection Distributors
- 8.2.3 Promethazine Hydrochloride Injection Customers
9 Global Promethazine Hydrochloride Injection Analyzing Market Dynamics
- 9.1 Promethazine Hydrochloride Injection Industry Trends
- 9.2 Promethazine Hydrochloride Injection Industry Drivers
- 9.3 Promethazine Hydrochloride Injection Industry Opportunities and Challenges
- 9.4 Promethazine Hydrochloride Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst